Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Gen Hosp Psychiatry. 2014 Jul 19;36(6):599–606. doi: 10.1016/j.genhosppsych.2014.07.004

Table 2.

INCPAD Incremental Cost Effectiveness Ratios

Effectiveness Metric * Δ Cost per patient Δ Effectiveness Incremental Cost-Effectiveness Ratio
DFD (Complete follow-ups) 1189.17 ($) 60.30 (DFD) 19.72 ($/DFD)
DFD (Complete and imputed follow-ups) 1189.17 ($) 44.12 (DFD) 26.95 ($/DFD)
QALY (derived from DFD complete follow-ups) 1189.17 ($) .066 QALY to .033 QALY 18,017.73 ($/QALY) to 36,035.45 ($/QALY)
QALY (derived from DFD complete and imputed follow-ups) 1189.17 ($) .048 QALY to .024 QALY 24,774.38 ($/QALY) to 49,548.75 ($/QALY)
QALY from EQ-5D 952.72 ($) .088 (QALY) 10,826.48 ($/QALY)
QALY from SF-12 (SF-6D) 952.72 ($) .013 (QALY) 73,286.92 ($/QALY)
*

DFD = depression-free day. QALY = quality-adjusted life year.